Many thanks to LBIC and Lucy Garnsworthy for featuring PharmaMedic’s insights on recent UK government initiatives to support pharma and medicaldevices regulatory innovation in its winter newsletter. The article features on page 6 of the newsletter.
We enjoyed a very engaging session for our latest virtual breakfast briefing examining the UK's role in the international life sciences community from innovation and regulatory perspectives. If you missed the event, or would like to recap the key takeaways, read our summary, and catch up with the recording here.
With the government, the MHRA has launched a new consultation to shape a new era of medical device regulation in the UK. The objective is to create a framework that improves patient and public safety, increases transparency in regulatory decision-making, and aligns with global best practices. In this article, we summarise the issues and the scope of the potential changes.
